ID
35418
Description
Study ID: 110978 Clinical Study ID: 110978 Study Title: A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, versus Oral Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus aureus Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00852540 https://clinicaltrials.gov/ct2/show/NCT00852540 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Retapamulin Ointment, Oral Linezolid Trade Name: N/A Study Indication: Skin Infections, Bacterial The study consists of 5 vists. The studys period extends over 19 days: Visit 1 (Day 1): Baseline (for both, topical and oral visit) Visit 2 (Day 3-4): On-Therapy (for both, topical and oral visit) Visit 3 (Day 7-9): End of Therapy for topical visit, On-Therapy for oral visit. Visit 4 (Day 12-14): Follow-up for topical visit, End of Therapy for oral visit. Visit 5 (Day 17-19): Final Follow-up for topical visit, Follow-up for oral visit. This document contains the concomitant medication and Subject product preference form. The concomitant medication has to be filled in if subject use concomitant medications during study.
Link
https://clinicaltrials.gov/ct2/show/NCT00852540
Keywords
Versions (3)
- 3/4/19 3/4/19 -
- 3/4/19 3/4/19 -
- 3/11/19 3/11/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
March 4, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Safety and efficacy of topical Retapamulin Ointment vs. oral Linezolid in Secondarily-Infected Traumatic Lesions and Impetigo due to MRSA, NCT00852540
Concomitant medication, Subject product preference
- StudyEvent: ODM
Description
Prior medications
Alias
- UMLS CUI-1
- C2347852
Description
(Trade Name preferred)
Data type
text
Alias
- UMLS CUI [1]
- C0013227
Description
Total Daily Dose
Data type
text
Alias
- UMLS CUI [1,1]
- C2348070
- UMLS CUI [1,2]
- C0013227
Description
Units
Data type
integer
Alias
- UMLS CUI [1]
- C1519795
Description
Route
Data type
integer
Alias
- UMLS CUI [1]
- C0013153
Description
Reason for Medication
Data type
text
Alias
- UMLS CUI [1]
- C2826696
Description
day month year
Data type
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0808070
Description
Taken prior to study
Data type
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0332152
- UMLS CUI [1,3]
- C2347804
Description
Ongoing of medication
Data type
text
Alias
- UMLS CUI [1]
- C2826666
Description
day month year
Data type
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Description
Subject medication preference
Alias
- UMLS CUI-1
- C3854006
- UMLS CUI-2
- C0030705
- UMLS CUI-3
- C0558295
Similar models
Concomitant medication, Subject product preference
- StudyEvent: ODM
C0013227 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,3])
C0806020 (UMLS CUI [1,2])
C0030705 (UMLS CUI-2)
C0558295 (UMLS CUI-3)
C0030705 (UMLS CUI [1,2])
C0558295 (UMLS CUI [1,3])